162 related articles for article (PubMed ID: 37683725)
1. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
Wessels HJCT; Kulkarni P; van Dael M; Suppers A; Willems E; Zijlstra F; Kragt E; Gloerich J; Schmit PO; Pengelley S; Marx K; van Gool AJ; Lefeber DJ
J Adv Res; 2024 Jul; 61():179-192. PubMed ID: 37683725
[TBL] [Abstract][Full Text] [Related]
2. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry based glycoproteomics--from a proteomics perspective.
Pan S; Chen R; Aebersold R; Brentnall TA
Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
[TBL] [Abstract][Full Text] [Related]
4. Towards structure-focused glycoproteomics.
Chernykh A; Kawahara R; Thaysen-Andersen M
Biochem Soc Trans; 2021 Feb; 49(1):161-186. PubMed ID: 33439247
[TBL] [Abstract][Full Text] [Related]
5. Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics.
Miura Y; Hashii N; Ohta Y; Itakura Y; Tsumoto H; Suzuki J; Takakura D; Abe Y; Arai Y; Toyoda M; Kawasaki N; Hirose N; Endo T
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1462-1471. PubMed ID: 29580922
[TBL] [Abstract][Full Text] [Related]
6. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
8. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
Schumacher KN; Dodds ED
Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
[TBL] [Abstract][Full Text] [Related]
9. Glycoproteomics: A Balance between High-Throughput and In-Depth Analysis.
Yang Y; Franc V; Heck AJR
Trends Biotechnol; 2017 Jul; 35(7):598-609. PubMed ID: 28527536
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutation-originated gain-of-glycosylation using mass spectrometry-based N-glycoproteomics.
Yang H; Tian Z
Rapid Commun Mass Spectrom; 2024 Sep; 38(17):e9838. PubMed ID: 38924612
[TBL] [Abstract][Full Text] [Related]
11. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
[TBL] [Abstract][Full Text] [Related]
12. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
[TBL] [Abstract][Full Text] [Related]
13. Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy.
Pan S; Tamura Y; Chen R; May D; McIntosh MW; Brentnall TA
Mol Biosyst; 2012 Nov; 8(11):2850-6. PubMed ID: 22892896
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in quantitative glycoproteomics.
Zhang Y; Yin H; Lu H
Glycoconj J; 2012 Aug; 29(5-6):249-58. PubMed ID: 22699565
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
16. The Hitchhiker's guide to glycoproteomics.
Oliveira T; Thaysen-Andersen M; Packer NH; Kolarich D
Biochem Soc Trans; 2021 Aug; 49(4):1643-1662. PubMed ID: 34282822
[TBL] [Abstract][Full Text] [Related]
17. Glyco-CPLL: An Integrated Method for In-Depth and Comprehensive N-Glycoproteome Profiling of Human Plasma.
Zhang Y; Mao Y; Zhao W; Su T; Zhong Y; Fu L; Zhu J; Cheng J; Yang H
J Proteome Res; 2020 Feb; 19(2):655-666. PubMed ID: 31860302
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry of transferrin glycoforms to detect congenital disorders of glycosylation: Site-specific profiles and pitfalls.
Wada Y
Proteomics; 2016 Dec; 16(24):3105-3110. PubMed ID: 27095603
[TBL] [Abstract][Full Text] [Related]
19. Maturing Glycoproteomics Technologies Provide Unique Structural Insights into the N-glycoproteome and Its Regulation in Health and Disease.
Thaysen-Andersen M; Packer NH; Schulz BL
Mol Cell Proteomics; 2016 Jun; 15(6):1773-90. PubMed ID: 26929216
[TBL] [Abstract][Full Text] [Related]
20. Advances in mass spectrometry driven O-glycoproteomics.
Levery SB; Steentoft C; Halim A; Narimatsu Y; Clausen H; Vakhrushev SY
Biochim Biophys Acta; 2015 Jan; 1850(1):33-42. PubMed ID: 25284204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
